T. N. Panina

T. N. Panina

Auto-generated profile, based on publicly available information

T. N. Panina

Burdenko Neurosurgical Center, Moscow, Russia

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 June 2015 in The Neurological Journal
Verified
Journal Article
Open access
PDF file
GEG. Yu. Evzikov
G. Yu. Evzikov
AFA. V. Faraphontov
A. V. Faraphontov
TPT. N. Panina
T. N. Panina
Представлен разбор клинического случая пациента с интраневральным ганглионом малоберцового нерва. Обсуждены патогенез, особенности клинической картины, методы диагностики и хирургическое лечение. Приводимый случай кисты малоберцового нерва является первым описанием данной патологии в русскоязычной литературе.

23 September 2020 in CLINICAL AND EXPERIMENTAL MORPHOLOGY
Verified
Journal Article
Closed access
PNP.V. Nikitin
P.V. Nikitin
MRM.V. Ryzhova
M.V. Ryzhova
APA.A. Potapov
A.A. Potapov
SGS.A. Galstyan
S.A. Galstyan
DKD.S. Kim
D.S. Kim
IZI.V. Zubova
I.V. Zubova
The heterogeneity of tumors properties is a serious diagnostic and therapeutic problem. It is manifested by the variability of genetic, proteomic and epigenetic parameters both between different samples of the same histological variant of the tumor, and between different sites within the same neoplasm with the presence of heterogeneous cell populations in this particular patient. Glioblastoma (GB) is one of the most frequent fatal tumors of the central nervous system in humans. The understanding the intertumor heterogeneity is the key to the development of both new diagnostic approaches and innovative personalized methods of patients’ management. In the framework of this review, the main data on intertumor heterogeneity of GB are sum-marized. The basic genetic, epigenetic and proteomic aspects of the modern understanding of GB molecular profile and intertumor heterogeneity are considered. Keywords: glioblastoma, intertumor heterogeneity, glioblastoma genetics, mutations

1 January 2022 in Russian Journal of Archive of Pathology
Verified
Journal Article
Closed access
MRM.V. Ryzhova
M.V. Ryzhova
SGS.A. Galstyan
S.A. Galstyan
ETE.N. Telysheva
E.N. Telysheva
ESE.G. Shaikhaev
E.G. Shaikhaev
GSG.P. Snigireva
G.P. Snigireva
TPT.N. Panina
T.N. Panina
Представлены 3 случая редких сарком ЦНС: две CIC-саркомы и одна DICER1-саркома. Опухоли были исследованы с помощью метода анализа структуры метилирования ДНК. Важно помнить, что первичные саркомы могут возникать в ЦНС и включать в перечень дифференциальной диагностики злокачественных опухолей исследования слияний CIC и мутации DICER1.

1 January 2020 in Burdenko's Journal of Neurosurgery
Verified
Journal Article
Closed access
PDF file
ПКП. Л. Калинин
П. Л. Калинин
DFD.V. Fomichev
D.V. Fomichev
ААА. А. Абдилатипов
А. А. Абдилатипов
ICI.V. Chernov
I.V. Chernov
ЛАЛ. И. Астафьева
Л. И. Астафьева
АКА. Б. Курносов
А. Б. Курносов
Neuroblastoma is a malignancy developing from the embryonic neuroblasts of sympathetic nervous system. Primary sellar neuroblastomas are extremely rare (there are currently only 11 case reports in the literature). Possible development of neuroblastoma in sellar region expands differential diagnosis of local processes due to inclusion of neuroblastoma into the spectrum of suspected tumors. We report a literature review and description of a patient with primary sellar neuroblastoma.

14 February 2023 in Russian Journal of Archive of Pathology
Verified
Journal Article
Closed access
MRM.V. Ryzhova
M.V. Ryzhova
SGS.A. Galstyan
S.A. Galstyan
LSL.V. Shishkina
L.V. Shishkina
TPT.N. Panina
T.N. Panina
EVE.I. Voronina
E.I. Voronina
AGAndrey Golanov
Andrey Golanov
На примере рецидивирующей опухоли с 10-летним катамнезом авторы показывают, что мутация генов IDH1/2 в астроцитомах не всегда является ранним событием в патогенезе глиомы, в редких случаях в астроцитомах может быть найдена коделеция 1p19q и IDH-мутантные опухоли могут возникать в детском возрасте.

1 January 2020 in CLINICAL AND EXPERIMENTAL MORPHOLOGY
Verified
Journal Article
Closed access
PNP.V. Nikitin
P.V. Nikitin
MRM.V. Ryzhova
M.V. Ryzhova
APA.A. Potapov
A.A. Potapov
SGS.A. Galstyan
S.A. Galstyan
DKD.S. Kim
D.S. Kim
IZI.V. Zubova
I.V. Zubova
Intratumoral molecular genetic heterogeneity is not a less significant challenge in modern oncology than the intertumoral. The presence of cell populations within the same tumor, differing in their molecular properties, translated into phenotypic features of the cells, is one of the reasons for the inefficiency of many developments in the field of tumor therapy and the basis for the progression of malignant neoplasms. The issue under consideration is very relevant for glioblastoma (GBM) – being one of the deadliest human tumors; it practically does not lend itself to even promising experimental treatment methods. Therefore, this paper reviews intratumoral heterogeneity. The review in this aspect examines new experimental data, including those obtained using single-cell technologies, in particular, the key cell populations that make up the pool of tumor cells in glioblastoma, and their molecular metamodules, the presumptive role of some cell populations and their subpopulations in providing tumor malignancy properties. A promising groundwork for fundamentally new approaches to creating personalized diagnostic and therapeutic methods is indicated. Keywords: glioblastoma, intratumoral heterogeneity, glioblastoma genetics, single-cell sequencing